Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urologic Endoscopic Procedure: Cystoscopic Examination01:28

Urologic Endoscopic Procedure: Cystoscopic Examination

3.7K
Meaning of Cystoscopic Examination:Cystoscopy is an essential diagnostic tool in urology that is used to assess the structure and function of the genitourinary system. It provides a direct view of the urethra, bladder, and, in some cases, the ureteral openings. This procedure helps detect structural abnormalities, infections, cancers, and blockages in the urinary tract. There are two types of cystoscopy:Flexible cystoscopy is commonly performed in outpatient settings due to its less invasive...
3.7K
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

300
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
300
Imaging Studies V: Intravenous Urography and Retrograde Pyelography01:22

Imaging Studies V: Intravenous Urography and Retrograde Pyelography

1.8K
IntroductionIntravenous Urography (IVU) and Retrograde Pyelography (RP) are important diagnostic imaging techniques used to evaluate the urinary system. These methods help identify structural abnormalities, obstructions, and functional issues in the kidneys, ureters, and bladder. Both procedures use iodine-based contrast media to enhance the visibility of urinary tract structures on X-ray images, though they differ in their methods and indications.1. Intravenous Urography (IVU)Intravenous...
1.8K
Imaging Studies II: Ultrasonography01:24

Imaging Studies II: Ultrasonography

553
IntroductionUltrasonography, or renal ultrasound, is a noninvasive medical imaging technique that uses high-frequency sound waves to visualize the kidneys, ureters, bladder, and surrounding tissues.Indications for Urinary System UltrasonographyUrinary system ultrasonography is indicated in various clinical scenarios, such as:Kidney Stones (Urolithiasis): To detect and monitor the size and presence of kidney or urinary tract stones.Hydronephrosis: To assess the dilation of the renal pelvis and...
553
Imaging Studies I: Kidney, Ureter, and Bladder Studies01:28

Imaging Studies I: Kidney, Ureter, and Bladder Studies

411
Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...
411
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

290
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
290

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colorectal Cancer Screening in Hereditary and Familial High-Risk Populations: Best Practices and Future Directions.

International journal of cancer·2026
Same author

Evaluating the reimbursement and cost-effectiveness of ureteroscopy for treating ureteral calculi: Pre-stented versus non-stented primary procedures.

Urologia·2026
Same author

Chest CT in Testicular Mass Evaluation: A Stepwise Approach to Minimize Radiation Exposure.

Urologia internationalis·2026
Same author

Managing healthcare for female BRCA carriers in the population screening era: developing a harmonized national policy for surveillance and risk-reduction.

Israel journal of health policy research·2026
Same author

The Expanding Role of the Urologist in Metastatic Prostate Cancer: From Biopsy to Surgical Interventions.

Rambam Maimonides medical journal·2026
Same author

Cryotherapy for non-muscle invasive bladder cancer-preliminary results in an animal model.

The Canadian journal of urology·2025

Related Experiment Video

Updated: Feb 20, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

15.7K

Update on Screening for Urological Malignancies.

Azik Hoffman1, Elizabeth E Half2,3

  • 1Division of Urology, Department of Surgical Oncology, Princess Margaret Hospital, Toronto, ON, Canada.

Rambam Maimonides Medical Journal
|October 24, 2017
PubMed
Summary

Screening for urological cancers like prostate cancer in men over 40 shows potential benefits but faces ongoing debate regarding effectiveness and optimal strategies. Emerging biomarkers may reshape future screening practices for these common malignancies.

More Related Videos

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

11.0K
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

907

Related Experiment Videos

Last Updated: Feb 20, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

15.7K
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

11.0K
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

907

Area of Science:

  • Urology
  • Oncology
  • Preventive Medicine
  • Biomarker Research

Background:

  • Urological malignancies represent a significant cause of morbidity and mortality in men over 40.
  • Screening for these cancers offers potential to reduce both disease burden and mortality rates.
  • Despite decades of prostate cancer screening, its implications, optimal protocols, and benefit-harm ratio remain subjects of considerable debate within the medical community.

Purpose of the Study:

  • To review current screening guidelines for common urological malignancies.
  • To provide an update on novel developments, including molecular and genetic biomarkers.
  • To discuss how these advancements may influence future screening strategies for urological cancers.

Main Methods:

  • Review of existing clinical guidelines for urological cancer screening.
  • Analysis of recent scientific literature and emerging research on screening modalities.
  • Discussion of the potential impact of new molecular and genetic biomarkers on screening practices.

Main Results:

  • Significant controversy persists regarding the effectiveness and optimal implementation of prostate cancer screening programs.
  • High-level evidence for screening urothelial and kidney tumors is still limited, though risk-stratified screening shows promise.
  • Advancements in molecular and genetic biomarkers are poised to significantly alter current screening paradigms.

Conclusions:

  • Current screening strategies for urological malignancies, particularly prostate cancer, lack universal consensus.
  • Further research and high-level evidence are needed to solidify screening benefits for urothelial and kidney tumors.
  • The integration of novel biomarkers holds substantial potential to refine and improve the efficacy of urological cancer screening in the future.